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Background: A study with the yellow passion fruit peel flour showed positive action in blood glucose control as
therapies’ adjuvant in patients with type 2 diabetes mellitus. Therefore, we evaluated its effect on insulin sensitivity
since there is a quest for studies that focus at better understanding of insulin resistance aspects in diabetic patients.
Furthermore its relationship with chronic complications can also give good prospects for alternative treatments.
Methods: A total of 43 type 2 diabetes volunteers (28 females and 15 males) ingested 30 g/day of the yellow
passion fruit peel flour for two months. The levels of blood glucose and fasting insulin, HOMA index and glycated
hemoglobin were measured for each patient before and after dietary supplementation.
Results: There was a significant difference in the fasting blood glucose values (P = 0.000) and glycated hemoglobin
(P = 0.032) after supplementation. It was also seen a reduction in HOMA IR (P = 0.005) in the supplemented group,
however it was not observed changes in insulin values for females. HOMA beta (P = 0.000) showed significant
increase in its values for the studied group.
Conclusions: The supplementation used decreased insulin resistance in type 2 diabetic patients, suggesting a
positive action in blood glucose control as adjuvant therapy in conventional treatments.Background
Epidemiological studies have shown that fiber rich diets
are associated with a reduced risk of diabetes and cardio-
vascular disease (CVD) [1-8] and it is inversely related to
insulin resistance (IR) [9]. However, the metabolic path-
way to enlighten the effects of dietary fiber remains with-
out a noteworthy explanation [10].
Pectin is a soluble fiber widely used as an ingredient in
pharmaceutical preparations as antidiarrheal and detoxi-
fying substance. Furthermore, it reduces glucose intole-
rance in diabetic patients and decreases serum cholesterol
and triglycerides levels [11,12] by forming a gel which pre-
vents the absorption of cholesterol and glucose derived
from the diet [10].* Correspondence: queirozsocorroramos@yahoo.com.br
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peel flour is rich in soluble fiber and has pectin as one of
its components [13]. Normal e diabetic guinea pigs fed
with the flour presented diabetes control, due to its
hypoglycemic action [14]. A clinical toxicological assay of
this flour was also performed with a daily intake of 30 g
and showed no acute or subchronic toxicity, suggesting its
use as a dietary supplement, making it feasible to carry
out further efficacy studies in people with diabetes be-
cause it is a product rich in soluble fiber [15].
Considering the yellow passion fruit peel flour, in
some studies, showed hypoglycemic action and can
be used as a dietary supplement, this study investigated its
effect on insulin sensitivity since the pursuit for research
projects aimed at better understanding IR aspects
in diabetic patients and its relationship with chronic
complications can also give good perspectives for alterna-
tive treatments.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Clinical data
The study was approved by the Paraiba State University
Ethics Committee (Opinion No. 0146.0.133.000-07). It
was a phase II and cross-interventionist clinical trial, using
the flour of the yellow passion fruit peel as a food supple-
ment. The flour was produced by “A.S.S. Neto’s Alimentos
Ltda” (CNPJ 82.112.708/0001-20) located in Rio de Janeiro
under the guidance of Professor Dr. Armando Oliveira
Ubirajara Sabaa Srur.
The patients were classified according to the American
Diabetic Association (ADA) [16] and their selection oc-
curred through random sampling from the population
attended by the Pharmaceutical Care Program (PROA-
TENFAR) from the Paraiba State University (UEPB). The
study excluded patients considered unfit during the inter-
view and/or physical examination, which showed changes
in laboratory tests such as: liver and renal dysfunction,
cardiac severe changes, alcoholism and those who chan-
ged diet, medical treatment or physical activity during the
study.
From June 2007 to June 2008, 60 patients were evalu-
ated, 36 women and 24 men, aged between 57 and
73 years, irrespective of ethnicity. Of these, 43 volunteers
remained at the end of the experiment, 28 female and
15 male. People who did not remain until the end aban-
doned the study due to the strong aftertaste of the flour
and abdominal discomfort. This has also been reported
in other studies and it is probably due to the hesperidin,
a substance present in the passion fruit mesocarp,
believed to be responsible for the residual bitter taste in
the flour [17]. Future trials need to be developed in
order to improve the taste, thereby contributing to a bet-
ter acceptance of the flour and hence the formulation of
functional foods.
Throughout the study, 09 diabetics patients were receiv-
ing glyburide, 09 used metformin, others were taking
other associations as follows: glyburide and metformin (11
people), metformin and insulin (07), glyburide and insulin
(01), insulin alone (05) and only 01 was not being treated
with hypoglycemic agents due to be recently diagnosed.
The drugs dosage was not changed during the study.
Each volunteer served as his own control. The study
protocol followed three different stages and, each one, was
carried out monitoring the patients fasting blood glucose
levels. In the first stage, we summarize the fasting blood
glucose values (FBS) of patients studied for the three
months prior to the ingestion of the yellow passion fruit
peel flour, when the patients were using drugs only. These
data were obtained by analyzing the database of the UEPB
Pharmaceutical Care Program (PROATENFAR) where
patients have medical care. The second stage involved
the measurement of all analysis parameters immediately
before the intervention (T0) and during the use ofsupplemental feeding with the passion fruit flour for 30
and 60 days (T30 and T60). The third stage (GP) consisted
of new tests after three months consumption of the flour
in order to verify if blood glucose levels would return to
baseline values or not.
Blood for laboratory tests was collected in the morning
after a 12-hour fasting in the UEPB clinical analysis la-
boratory to obtain serum, which was packaged and
transported in refrigerated containers to the Lauro Wan-
derley University Hospital Clinical Laboratory, where
biochemical tests were realized. Four blood collections
were carried out during the following stages: before sup-
plementation (T0), during supplementation (T30 and
T60) and after supplementation (GP), in the latter only
fasting blood glucose was performed as a final control.
After the collection called T0 (before intervention),
each patient under study received seven 30 g plastic bags
of flour weekly, corresponding to 17.4 g of total fiber,
being 6.3 g of soluble fiber and 11.1 g of insoluble fiber
[18], to be eaten throughout the day along with food,
which may include, among others, juices, fruits and
milk. Because the flour is rich in pectin, a water-soluble
fiber, patients were instructed to ingest at least two liters
of water per day, since the low intake of this liquid could
cause constipation [19].Anthropometric indicators
Among the anthropometric indicators were recorded:
height, weight and Body Mass Index (BMI).
Height and weight were verified using a Filizola metal
rod scale, measuring two meters and divided into 0.5 cm
fractions with a 150 kg capacity and 100 g increase. The
patient was positioned upright, looking towards the hori-
zon, barefooted with their heels together, back straight
and arms extended at their sides.
BMI was calculated by dividing weight (kg) by squared
height (m2), using the BMI ranges, adopted for nu-
tritional classification according to the World Health
Organization [20].Laboratory data
Serum concentrations of glucose were determined using
BiosystemsW kits and BiosystemW A-25 analyzer; the de-
termination of baseline insulin values was performed in
the IMMULITEW (immunometric procedure) to IR as-
sess in patients and determination of the glycated
hemoglobin (HbA1c) was determined by the Biosys-
temsW Turbidimetry method and reference values were
based on those adopted by the International Federation
of Clinical Chemistry (IFCC).
The insulin variables, HOMA IR and HOMA Beta,
were performed in 32 patients of both genders of the
same clinical group studied in the same period (19
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cient volume of the samples.
HOMA (Homeostasis Model Assessment), is a mathe-
matical model that evaluates the relationship between
glycemia and insulin and allows analyzing individuals in
different IR severity conditions [21]. Furthermore, it is a
low cost method, of easy implementation and large scale
use [22]. Two indexes are extracted form it (HOMA IR
and HOMA beta), designed to translate the insulin sen-
sitivity and secretory capacity of beta cells. Thus, the
model predicts insulinemia and glucose for a given sen-
sitivity and insulin secretion capacity, assuming the RI
would be the same in the liver and peripheral tissues
in order to estimate insulin sensitivity throughout the
body [23].
Reference values for the IR diagnosis - baseline insulin:
2-27 μUI/mL; HOMA IR up to 2.7 and HOMA Beta:
150-380 (“Pró –Sangue” Diagnosis Lab, where insulin
dosages were made).
Statistical analyses
At first the data were stored in a Microsoft ExcelW sheet.
The descriptive statistical analysis was performed using
the Epi-Info software, versions 6.04 and 3.4 and SPSS
version 14, by applying the paired Student t test. For all
statistical tests performed, we considered the 95% confi-
dence interval and a significance level of 5% (p ≤ 0.05).
Results were reported as Mean ± Standard Deviation
(M ± SD).
Results
The participants body weight remained constant in
the first 30 days (p = 0.472) and was highest at 60 days
(p = 0.000). In the nutritional diagnosis, BMI was used,
which had at the beginning of treatment the overall ave-
rage of 27.76 ± 3.24 kg/m2, at the end of the study, these
values became 28.13 ± 3.16; 28.62 ± 2:48; 28.13 ± 3.16,
respectively, showing that overweight was present both
at baseline, and at the end of treatment (Table 1).
A comparison between average values of fasting blood
glucose of all patients (n = 43) performed in the periodTable 1 Baseline values (weight, BMI) and average difference
study
Parameters Period Average ± SD
T
Weight(kg) T0 66.78 ± 9.60 0.174 ±
T30 66.60 ± 9.50 p = 0.4
T60 67.84 ± 9.50
BMI (kg/m2) T0 27.76 ± 3.24 -0.140
T30 27.81 ± 3.41 p = 0.3
T60 28.13 ± 3.16
P ≤ 0.05 = Significance level; n = 43; SD = Standard deviation; T0 = Baseline time; T3before and after the intervention, when patients did not
use the passion fruit flour, showed that these values did
not vary significantly (Table 2).
A parallel of fasting blood glucose average levels of all
patients (n = 43) immediately before (TO) and during
the intervening period (T30 and T60) shows that there
was a significant difference between them (Table 3).
There was a 14.6% reduction in blood glucose during
the first 30 days and 25.7% after 60 days when patients
took the passion fruit flour as a daily food supplement.
HbA1c also presented a significantly difference during
the study, following the reduction in the average values
of fasting blood glucose.
As shown in Table 4, the insulin values remained con-
stant even after supplementation while HOMA IR
showed low levels with a significant difference at 60 days
of the study. HOMA beta had higher average values in
both the first four weeks of intervention and at the end
of the study.
As also shown in the table above there was no signifi-
cant change in insulin values in females, whereas among
men there was an increase in insulin levels after both
the first 30 days and at the end of the study. Regarding
HOMA IR checked at baseline, greater IR in females,
which was decreased during the study; that did not oc-
curred to males. For the HOMA Beta variable, an in-
crease is seen in the average values in both groups
throughout the study period, with a significant difference
at 60 days of study for females. The males showed sig-
nificance in their values in both established times.
Discussion
Regarding the body weight no significant difference was
observed during the study. One explanation for these
data could be related to the short period of use of the
passion fruit flour causing limitation on the population
studied to assess the weight loss, gain or invariability.
Evaluated overweight, obese and placebo patients
for 16 weeks suggesting that diet supplementation with
soluble fiber for weight reduction could be beneficial
because fiber induces satiety and a more favorableand standard deviations (SD) at 30 and 60 days of the
Difference between the averages on the entire sample
0/T30 T30/T60 T0/T60
1.57 -1.233 ± 1.48 -1.058 ± 1.72
72 p = 0.000 p = 0.000
± 1.01 -0.279 ± 1.14 -0,372 ± 0,72
72 p = 0.116 p = 0.001
0 = 30 days; T60 = 60 days; BMI = Body mass index.
Table 2 Control of fasting blood glucose in the different
study stages monitoring
Glycemia (mg/dL) Average ± SD Difference between the averages
GA/G0 GA/GP G0/GP
GA 162.33 ± 69.83 p = 0.971 p = 0.797 p = 0.664
G0 162.56 ± 52.01
GP 160.12 ± 56.02
P ≤ 0.05 = significance level; n = 43; SD = standard deviation; GA = Blood
glucose three months prior study; GO = Blood glucose at baseline time;
GP = Blood glucose three months after supplementation.
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results do not support the hypothesis that fiber supple-
ments may have additional effects on weight loss, since
they were not statistically significant in this group. Stu-
died the effect of high dietary fiber intake (50 g) in
patients with DM2, for 6 weeks, and the results were
also not significant for body weight reduction [25].
Most individuals in this study were not able to keep their
blood glucose levels in the range considered normal even
using drug therapy. We analyzed the fasting blood glucose
levels three months before the study and three months
after the end of it and obtained, respectively, the average
values of 162.33 mg/dl and 160.12 mg/dl; confirming that
these patients actually were uncompensated and justifying
the importance of using an alternative treatment method
in an attempt to reduce blood glucose levels.
In the present study, we observed a statistically signifi-
cant reduction in fasting plasma glucose at 30 and
60 days of treatment with the passion fruit flour. One
possible explanation for this effect would be the pres-
ence of fibers in the food, mainly pectin, which form vis-
cous mixtures (gel formation) which can change the
gastric emptying time, increase satiety and delay the ab-
sorption of simple carbohydrates. Moreover, this gel is
still able to form complexes with bile salts increasing the
cholesterol excretion and may be used for cardiovascular
disease, obesity, lipid disorders and diabetes mellitus
type 2 treatment or prevention [10].
Besides the reduction in the average baseline glucose
values, it was observed a significant reduction in HbA1cTable 3 Difference in the average baseline values and SD at 3
Biochemical variables Period Average ± SD
Glucose (≤ 110 mg/dL) T0 162.55 ± 52.09
T30 138. 88 ± 41.46
T60 120.83 ± 36.72
Glycosylated Hb (≤ 6.4%) T0 6.58 ± 3.04
T60 5.71 ± 1.82
T30 185.07 ± 92.71
T60 161.21 ± 91.09
P ≤ 0,05 = significance level; n = 43; SD = Standard Deviation; T0 = baseline time; T3values between baseline and 60 days in patients treated
with the passion fruit flour. These results are consistent
with other studies, which demonstrated that fiber intake
improves control and reduces the risk of chronic com-
plications of type 2 diabetes [8,10,26,27]. However, in re-
lation to the glycemic levels achieved, the results of
different studies showed variations.
It is important to note that HbA1c has a fundamental
role in monitoring the glycemic control in diabetic
patients because it provides information about the retro-
spective index of plasma glucose (60 to 90 days of the
exam). The great advantage of HbA1c consists in not
suffering from significant fluctuations, as in the deter-
mination of plasma glucose, as well as being directly
related to the risk of complications in patients with
DMT2 [28]. In this study this dosage was performed
only at 60 days of supplementation because it is the
period of the clinical study.
Among patients with type 2 diabetes treated with glib-
enclamide and dietary restrictions that used conven-
tional diet supplemented with psyllium (seed husk of
Plantago ovata), we observed a decrease of 12.2% in glu-
cose uptake (significant difference) and a not significant
reduction in HbA1c [29]. Supplementing with passion
fruit flour made in this study provided a 25.7% reduction
in fasting blood glucose while in HbA1c it was 13.2%.
Other researchers have studied the effect of dietary
fiber from rice bran involving diabetic patients treated
with insulin. Hypoglycemic agents or diet control
showed that the average fasting and postprandial blood
glucose levels were reduced (p <0.001) when subjected
to the diet with 40 g of the rice bran fiber during two
weeks [30].
The effects of ingestion of food based on parameters
recommended by the American Diabetes Association
(ADA), containing moderate amounts of dietary fiber
(total of 24 g, being 8 g of soluble fiber and 16 g of in-
soluble fiber) and also the consumption of higher fiber
dietary levels (50 g in total, in equal proportions) in
patients with type 2 diabetes, most of them in use of medi-
cation, within six weeks, were evaluated and compared0 and 60 days of the patients glycemic profile
Difference between the averages on the entire sample
T0/T30 T30/T60 T0/T60
23.67 ± 32.45 18.05 ± 33.44 41.72 ± 38.11
p = 0.000 p = 0.001 p = 0.000
- - 0.88 ± 2.62
p = 0.032
0 = 30 days; T60 = 60 days.




Average ± SD Difference between averages by gender
T0/T30 T30/T60 T0/T60
Female Male p Female Male Female Male Female Male
Insulin
(μUI/mL)
T0 7.97 ± 3.18 4.52 ± 2.81 0.004 1.00 ± 2.88 -2.53 ± 2.73 -0.42 ± 3.24 1.31 ± 2.14 0.74 ± 3.83 -1.00 ± 1.47
T30 6,86 ± 3.25 6.89 ± 4.87 0.923 p = 0.146 p = 0.006 p = 0.578 p = 0.047 p = 0.412 p = 0.031
T60 7.20 ± 4.19 5.54 ± 4.06 0.662
HOMA IR T0 3.17 ± 1.65 1.76 ± 1.54 0.006 0.95 ± 1.31 -0.77 ± 1.17 0.21 ± 1.23 0.77 ± 1.09 1,21 ± 1,62 0.08 ± 0.49
T30 2.28 ± 1.12 2,61 ± 2.46 0.684 p = 0.005 p = 0.035 p = 0.465 p = 0.026 p = 0.004 p = 0.584
T60 2.04 ± 1.34 1.75 ± 1.65 0.907
HOMA
Beta
T0 36.84 ± 22.78 21.54 ± 12.23 0.037 -4.37 ± 19,69 -16.77 ± 16.70 -22.58 ± 40.21 -4.61 ± 25.47 -26.95 ± 41.07 -21.38 ± 19.59
T30 41.21 ± 27.48 38.31 ± 23.57 0.611 p = 0.346 p = 0.003 p = 0.025 p = 0.526 p = 0.010 p = 0.001
T60 63.79 ± 51.22 42.92 ± 27.92 0.259
P ≤ 0.05 = significance level; n = 32; SD = Standard Deviation; T0 = baseline time; T30 = 30 days; T60 = 60 days; HOMA IR = Homeostasis Model Assessment-insulin
resistance; HOMA Beta.
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in the average concentrations of plasma glucose and a
slight reduction of HbA1c (P = 0.09) [25].
The consumption of the yellow passion fruit peel flour
in patients with type 2 diabetes in the present study
showed a significant increase in HOMA beta, both in gen-
eral and in males and females during the established time,
as there was a decrease in IR especially in females. These
findings demonstrated that consumption of fiber is benefi-
cial for the type 2 diabetes and CVD control. This corro-
borates with a study that evaluated fiber intake in diabetic
patients in which was observed attenuation of IR [1].
The assay with hyperinsulinemic and hypertensive
patients of both genders, who were fed with soluble
fiber, indicated the improvement in insulin sensitivity
[31]. Similarly, the findings of this study also showed an
IR decrease, suggesting an increased sensitivity at 60 days
of supplementation. Also significant beneficial effects of
daily intake of soluble and insoluble fiber (25 g each)
were observed for six weeks, in patients with type 2 dia-
betes under pharmacological treatment, which showed
decrease in insulin levels [25]. However, insulin values
were unchanged in this study population over the time
established; with respect to the gender, there was a de-
crease in the figures only in males.
Some researchers studied 347 patients with metabolic
syndrome diagnosed as normal, glucose intolerants and
type 2 diabetes, and they found that the HOMA IR
values increased while HOMA Beta diminished in
patients with type 2 diabetes. This indicates therefore
that the ability of beta cell secretion determines the oc-
currence of type 2 diabetes. Therefore, substances that
act on insulin resistance decrease and increase the beta
cell secretion function is relevant for the treatment of
patients with the above-mentioned condition [25].It was shown that dietary fiber improves the sensitivity
to insulin in diabetics and non-diabetic [32,33] as well as
in experimental animal models [34]. Research in sponta-
neously hypertensive rats predisposed to stroke suggested
supplementation with psyllium soluble fiber effectively
prevents IR by increasing the content of GLUT4 in the
plasma membrane of skeletal muscle without activation of
the PI3 kinase. One hypothesis for this increase may be
related to a series of fatty acids that would stimulate the
peroxisome proliferator activation receptorγ (PPARγ)
whose activation increases the content of GLUT4 in adi-
pocytes. It is unlikely that short chain fatty acids such as
propionic and butyric acids, which results from the anaer-
obic bacteria fermentation of soluble dietary fiber in the
colon, raise the GLUT4 muscle via PPARγ [35].
Although no mechanism has been described to explain
the benefits of insoluble fiber, their use enhances insulin
sensitivity in the body [36]. Ingestion of these fibers within
the RDA [37] significantly accelerates insulin response,
an effect that was associated with an increase in the post-
prandial active amounts of the glucose-dependent in-
sulin tropic peptide incretin hormone (GIP), while the
glucagon-like peptide 1 (GLP-1) was not affected [10]. In
contrast, the soluble dietary fibers, such as oligofructose,
have been described to increase the secretion and concen-
tration of GIP and GLP-1 [38-40]. These short-term
effects do not appear to be influenced by colonic fermen-
tation. Thus, long-term studies, with the inclusion of indi-
viduals with damaged glucose metabolism should be
performed in order to confirm these findings, as well as
other techniques using animal models could be studied in
order to elucidate the mechanisms involved in the effects
of both soluble and insoluble fiber in insulin sensitivity
and the role played by the incretin hormones in such
mechanisms [10].
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dietary fiber on insulin sensitivity is the attenuation of
the glycemic response to carbohydrate intake through
their mechanical action in the intestine, where they tend
to slow the absorption of nutrients [40,41]. The reduc-
tion of serum glucose concentration decreases the
amount of insulin necessary to capture it; over time, the
reduction in insulin concentration in the environment
can result in regulation of insulin receptors on the cell
surface, thus increasing insulin sensitivity [34].
Conclusions
Before the results obtained in this study, the intake of
fiber-rich flour (pectin) suggests a favorable effect on insu-
lin sensitivity during the eight-week period in the studied
adults. These effects may reduce the risk of chronic com-
plications of type 2 diabetes. Although larger and longer
trials are needed to confirm these results and elucidate
the mechanisms involved, evidence-based literature are
enough to encourage increased consumption of foods rich
in dietary fiber.
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